imipramine (Q58396)

image of molecular model or crystal lattice model

17 November 2015

Imipramine-3D-balls.png
1,811 × 2,000; 511 KB

depicts

ball-and-stick model

0 references

mass

280.194 dalton

1 reference

imipramine (English)

17 November 2016

C₁₉H₂₄N₂

1 reference

imipramine (English)

17 November 2016

CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31

1 reference

World Health Organisation international non-proprietary name

imipramine (English)

17 November 2016

1 reference

14 February 2018

imipramine (English)

1 reference

imipramine (English)

medical condition treated

19 October 2016

attention deficit hyperactivity disorder

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

Food and Drug Administration

13 December 2016

21 May 1984

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/OGG85SX4E4

2 November 2018

reference URL

http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf

significant drug interaction

isocarboxazid

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

procarbazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(±)-deprenyl

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

( -)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

guanfacine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lithium

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

( -)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-nefopam

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

delirium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bupropion

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urinary retention

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urinary retention

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urinary retention

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Potassium inwardly-rectifying channel, subfamily J, member 6

1 reference

Potassium inwardly-rectifying channel, subfamily J, member 5

17 August 2016

1 reference

Potassium voltage-gated channel subfamily H member 1

17 August 2016

1 reference

Cholinergic receptor muscarinic 2

17 August 2016

1 reference

Solute carrier family 6 member 2

17 August 2016

1 reference

solute carrier family 6 member 4

17 August 2016

1 reference

Australian pregnancy category C

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category N

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category B

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Imipramine

last update

25 April 2018

selective serotonin reuptake inhibitor

1 reference

5 March 2018

adrenergic uptake inhibitors

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

D007099

15 March 2018

tricyclic antidepressant

1 reference

InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3

Medical Subject Headings

15 March 2018

Imipramine

0 references

Identifiers

InChI

1 reference

imipramine (English)

17 November 2016

2 references

imipramine (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

50-49-7

2 references

imipramine (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=50-49-7

10 April 2021

1 reference

Imipramine (English)

17 November 2016

2 references

imipramine (English)

17 November 2016

Reaxys registry number

256892

1 reference

imipramine (English)

19 October 2016

1572523

0 references

ChEBI ID

47499

mapping relation type

3 references

IMIPRAMINE (English)

17 November 2016

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3

1 reference

IMIPRAMINE (English)

17 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU150806

1 reference

MassBank accession ID

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003874

0 references

MSBNK-Waters-WA000794

0 references

MSBNK-Waters-WA000795

0 references

MSBNK-Waters-WA000796

0 references

MSBNK-Waters-WA000797

0 references

MSBNK-Waters-WA000798

0 references

SPLASH

splash10-0019-7495000000-3fb4d40b6a219f088ec8

0 references

splash10-0543-8895000000-6cf8e84f007ce7c750f2

0 references

splash10-0ab9-9432000000-033c51459b692622ee7d

0 references

splash10-000i-9500000000-eb3c0ecdffc5d9d95e33

0 references

splash10-000i-9500000000-55d924fd00e5b357ce9e

0 references

NMRShiftDB structure ID

20147315

1 reference

HSDB ID

3100

1 reference

Hazardous Substances Data Bank

28 October 2019

IMIPRAMINE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

imipramine (English)

ECHA Substance Infocard ID

17 November 2016

100.000.039

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Imipramine (English)

CAS no.: 50-49-7 (English)

1 reference

Imipramine (English)

publication date

17 November 2015

1 reference

imipramine (English)

17 November 2016

Imipramine

0 references

0 references

0 references

1 reference

imipramine (English)

17 November 2016

1 reference

Human Metabolome Database ID

HMDB0001848

2 references

based on heuristic

inferred from InChIKey

2 references

imipramine (English)

17 November 2016

MedlinePlus drug identifier

0 references

1 reference

imipramine (English)

17 November 2016

0 references

1 reference

1 reference

Encyclopædia Britannica Online ID

imipramine (English)

19 October 2016

0 references

0 references

0 references

science/imipramine

subject named as

imipramine

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

2Q72 (English)

Store medisinske leksikon ID

19 October 2016

imipramin

mapping relation type

exact match

subject named as

imipramin

1 reference

Great Norwegian Encyclopedia

29 May 2020

1 reference

imipramine (English)

17 November 2016

0 references

WordNet 3.1 Synset ID

03567069-n

1 reference